Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

8(88.9%)

Phase 4

1(11.1%)

9Total

N/A(8)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT00260247Phase 4Completed

Induction of Drug Metabolism: In Vivo Comparison of Carbamazepine and Oxcarbazepine.

Role: collaborator

NCT00482651Not ApplicableCompleted

Imaging of Vulnerable Plaques in Coronary Artery Disease by Multidetector Computed Tomography

Role: collaborator

NCT00266292Not ApplicableUnknown

The Effect of n-3 LCPUFA on Immune Function and Cardiovascular Risk Factors

Role: collaborator

NCT00271752Not ApplicableCompleted

The Procalcitonin and Survival Study

Role: collaborator

NCT00265421Not ApplicableCompleted

Study of Different Suturing Techniques for Perineal Repair After Delivery

Role: collaborator

NCT00464035Not ApplicableCompleted

The Effect of Calcium on Postprandial Lipid Profile and Appetite

Role: collaborator

NCT00266305Not ApplicableCompleted

Fish Oil Supplementation in Lactation

Role: collaborator

NCT00389129Not ApplicableCompleted

Danish Aspirin Resistance Trial - Pilot Study

Role: collaborator

NCT00519909Not ApplicableUnknown

The Effect of Calcium on Fecal Fat and Energy Excretion

Role: collaborator

All 9 trials loaded